Last year, Techcouver reported on a local property management firm helping turn a pocket of the city into a world-class bio-technology hub. Low Tide Properties, co-founded in 2011 by Vancouver celebrity entrepreneur Chip Wilson, has been advancing Great North Way in Vancouver as a biotech hotspot within Canada. This plan includes the launch of Lab […]
Nanovation Therapeutics
NanoVation Bolsters Board, Captures Capital to Advance Novel Biotech
A B.C. company developing technologies to overcome barriers to nucleic acid delivery has announced a funding round. Vancouver’s NanoVation Therapeutics raised financing from Convergent Ventures, an early-stage venture capital firm focused on founders working on science-based technologies impacting health. The new financing will support advancement of NanoVation’s lipid nanoparticle technology platform for RNA delivery to […]
NanoVation and Novo Nordisk in $600M Partnership for Genetic Medicines
Vancouver biotech NanoVation Therapeutics has announced a multi-year partnership with Novo Nordisk to advance the development of novel genetic medicines targeting cardiometabolic and rare diseases. With the partnership, NanoVation will receive research funding and is eligible to receive up to approximately USD $600 million in up-front cash and potential milestone payments, as well as tiered […]
Innovate BC Awards $2.3 Million to B.C. R&D Projects
Last week at an awards ceremony in Vancouver, Innovate BC awarded $2,325,000 to eight B.C. research and development projects that are creating game-changing innovations that are improving lives for British Columbians. Specifically, this year’s funding, through Innovate BC’s Ignite program, is accelerating the commercialization of biotech, cleantech, mining, agriculture, and forestry projects. “Innovation in is […]